Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2018, Article ID 8432859, 5 pages
https://doi.org/10.1155/2018/8432859
Research Article

Effectiveness and Adverse Effect of Intravenous Lacosamide in Nonconvulsive Status Epilepticus and Acute Repetitive Seizures in Children

1Neurology Division, Department of Pediatrics, Phramongkutklao Hospital, Bangkok, Thailand
2Department of Pharmacology, Phramongkutklao College of Medicine, Bangkok, Thailand

Correspondence should be addressed to Piradee Suwanpakdee; gro.kmpdep@eedarip

Received 23 January 2018; Revised 4 April 2018; Accepted 6 May 2018; Published 10 June 2018

Academic Editor: Vincenzo Di Lazzaro

Copyright © 2018 Monsicha Ngampoopun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. M. Brophy, R. Bell, J. Claassen et al., “Guidelines for the evaluation and management of status epilepticus,” Neurocritical Care, vol. 17, no. 1, pp. 3–23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Garces, V. Villanueva, J. A. Mauri, A. Suller, C. Garcia, F. J. Lopez Gonzalez et al., “Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study,” Epilepsy & behavior: E & B, pp. 36–144, 2014. View at Google Scholar
  3. V. Biton, W. E. Rosenfeld, J. Whitesides, N. B. Fountain, N. Vaiciene, and G. D. Rudd, “Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures,” Epilepsia, vol. 49, no. 3, pp. 418–424, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Finsterer and M. Frank, “Beneficial effect of lacosamide for mitochondrial epilepsy,” Epilepsy Research, vol. 140, pp. 95-96, 2018. View at Publisher · View at Google Scholar
  5. I. Pasha, M. Kamate, and D. K. Suresh, “Safety of lacosamide in children with refractory partial epilepsy,” Saudi Pharmaceutical Journal, vol. 23, no. 5, pp. 556–561, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. E. P. Yildiz, M. U. Ozkan, G. Bektas et al., “Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients,” Child's Nervous System, vol. 33, no. 11, pp. 2023–2027, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Kellinghaus, S. Berning, and M. Besselmann, “Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy,” Epilepsy & Behavior, vol. 14, no. 2, pp. 429–431, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Höfler, I. Unterberger, J. Dobesberger, G. Kuchukhidze, G. Walser, and E. Trinka, “Intravenous lacosamide in status epilepticus and seizure clusters,” Epilepsia, vol. 52, no. 10, pp. e148–e152, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Shiloh-Malawsky, Z. Fan, R. Greenwood, and M. Tennison, “Successful treatment of childhood prolonged refractory status epilepticus with lacosamide,” Seizure, vol. 20, no. 7, pp. 586–588, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Casas-Fernandez, A. Martinez-Bermejo, M. Rufo-Campos, P. Smeyers-Dura, JL. Herranz-Fernandez, S. Ibanez-Mico et al., “Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain,” Drugs in R & D, vol. 12, pp. 187–97, 2012. View at Publisher · View at Google Scholar
  11. I. Pasha, M. Kamate, and S. K. Didagi, “Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy,” Pediatric Neurology, vol. 51, no. 4, pp. 509–514, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. W. R. Yorns, D. S. Khurana, K. S. Carvalho, H. H. Hardison, A. Legido, and I. Valencia, “Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy,” Journal of Child Neurology, vol. 29, no. 1, pp. 23–27, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Miró, M. Toledo, E. Santamarina et al., “Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: A multicentric prospective study,” Seizure, vol. 22, no. 1, pp. 77–79, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Arkilo, M. Gustafson, and F. J. Ritter, “Clinical experience of intravenous lacosamide in infants and young children,” European Journal of Paediatric Neurology, vol. 20, no. 2, pp. 212–217, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Grosso, N. Zamponi, A. Bartocci et al., “Lacosamide in children with refractory status epilepticus. A multicenter Italian experience,” European Journal of Paediatric Neurology, vol. 18, no. 5, pp. 604–608, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Poddar, R. Sharma, and Y.-T. Ng, “Intravenous Lacosamide in Pediatric Status Epilepticus: An Open-Label Efficacy and Safety Study,” Pediatric Neurology, vol. 61, pp. 83–86, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. S. M. Wilson and R. Khanna, “Specific Binding of Lacosamide to Collapsin Response Mediator Protein 2 (CRMP2) and Direct Impairment of its Canonical Function: Implications for the Therapeutic Potential of Lacosamide,” Molecular Neurobiology, vol. 51, no. 2, pp. 599–609, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Sarkar, G. Chandra, S. Peng, Z. Zhang, A. Liu, and A. B. Mukherjee, “Neuroprotection and lifespan extension in Ppt1-/- mice by NtBuHA: Therapeutic implications for INCL,” Nature Neuroscience, vol. 16, no. 11, pp. 1608–1617, 2013. View at Publisher · View at Google Scholar · View at Scopus